Dose-response relationship of insulin glulisine in subjects with type 1 diabetes

Diabetes Care

Volumn 30, Issue 10, 2007, Pages 2506-2507

  Becker, Reinhard H A ^a   Frick, Annke D ^a   Nosek, Leszek ^b   Heinemann, Lutz ^b   Rave, Klaus ^b  

^a SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

^b Profil Institute for Metabolic Research   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN DERIVATIVE; INSULIN GLULISINE; RECOMBINANT HUMAN INSULIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOSE RESPONSE; DRUG ABSORPTION; DRUG EXPOSURE; GLUCOSE TOLERANCE TEST; HUMAN; INFUSION RATE; INSULIN DEPENDENT DIABETES MELLITUS; MALE; RANDOMIZED CONTROLLED TRIAL;

ADULT; BLOOD GLUCOSE; BODY MASS INDEX; DIABETES MELLITUS, TYPE 1; DOSE-RESPONSE RELATIONSHIP, DRUG; GLUCOSE CLAMP TECHNIQUE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; HYPOGLYCEMIC AGENTS; INJECTIONS, SUBCUTANEOUS; INSULIN; KINETICS; MALE; METABOLIC CLEARANCE RATE;

EID: 35148874608     PISSN: 01495992     EISSN: 01495992     Source Type: Journal    
DOI: 10.2337/dc06-2114     Document Type: Article

References (7)

1. Bolli GB, Di Marchi RD, Park GD, Pramming S, Koivisto VA: Insulin analogues and their potential in the management of diabetes mellitus. Diabetologia 42:1151-1167, 1999
2. Monnier L, Colette C: Contributions of fasting and postprandial glucose to hemoglobin A1C. Endocr Pract 12 (Suppl. 1):42-46, 2006
3. Hennige AM, Kellerer M, Strack V, Metzinger E, Seipke G, Haring HU: New human insulin analogs: characteristics of insulin signalling in comparison to ASP (B10) and regular insulin (Abstract). Diabetologia 42:A178, 1999
4. Bakaysa DL, Radziuk J, Havel HA, Brader ML, Li S, Dodd SW, Beals JM, Pekar AH, Brems DN: Physicochemical basis for the rapid time-action of LysB28ProB29-insulin: dissociation of a protein-ligand complex. Protein Sci 5:2521-2531, 1996
5. Kang S, Brange J, Burch A, Volund A, Owens DR: Subcutaneous insulin absorption explained by insulin's physicochemical properties: evidence from absorption studies of soluble human insulin and insulin analogues in humans. Diabetes Care 14:942-948, 1991
6. Robinson DM, Wellington K: Insulin glulisine. Drugs 66:861-869, 2006
7. Garg SK, Rosenstock J, Ways K: Optimized basal-bolus insulin regimens in type 1 diabetes: insulin glulisine versus regular human insulin in combination with basal insulin glargine. Endocr Pract 11:11-17, 2005